Regulatory Approved Software for Mutation Analysis in Cancer

Project description

New software to analyse anti-cancer drugs

Fields of science

• natural sciences › computer and information sciences › software
• natural sciences › biological sciences › genetics and heredity › dna
• natural sciences › biological sciences › genetics and heredity › mutation
• medical and health sciences › clinical medicine › cancer
• social sciences › economics and business › business and management › commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

ONCODIA AB

Address

C/o Uu Holding Innovation Hub Science Park
751 83 Uppsala
Sweden

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000